➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
Baxter
Colorcon
Moodys

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences Inc. v. Abbvie Inc. (D. Del. 2013)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Gilead Sciences Inc. v. Abbvie Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for Gilead Sciences Inc. v. Abbvie Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-11-03 236 the asserted claims of U.S. Patent Nos. 8,466,159 (the'" 159 Patent") and 8,492,386 (the … ORDER CONSTRUING THE TERMS OF U.S. PATENT NOs. 8,466,159 & 8,492,386. Signed by Judge Gregory M. … ORDER CONSTRUING THE TERMS OF U.S. PATENT NOs. 8,466,159 & 8,492,386 After having considered…the '"386 Patent"): The term "treatment for HCV" is construed to have its…language of the claim in construing the terms of a patent. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d External link to document
2014-04-10 32 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,466,159 B2; US 8,492,386 …18 December 2013 1:13-cv-02034-GMS Patent Plaintiff District Court, D. External link to document
2014-04-10 33 States patent laws. Both PSI-7977 and GS-5885 are protected by United States Patents Nos.7,964,580, 8,334,270…protected by several United States patents, including U.S. Patent Nos. 7,964,580, 8,334,270, and 8,580,765. …violating the U.S. Patent Law. Gilead Pharmasset LLC owns U.S. Patent No. 7,964,580, which covers PSI…including, among others U.S. Patent No. 7,964,580 B2 (“the Gilead ’580 patent”) and U.S. …2690 limited to the following issued U.S. Patents: 7,964,580, 8,334,270, and 8,580,765 (PSI/GS-7977 - External link to document
2013-12-18 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,466,159 B2; US 8,492,386 …18 December 2013 1:13-cv-02034-GMS Patent Plaintiff District Court, D. External link to document
2015-01-21 69 willful patent infringement. The patents-at-issue are U.S. Patent Nos. 8,466,159 (“the ’159 patent”), 8,492,3868,492,386 (“the ’386 patent”), 8,680,106 (“the ’106 patent”), 8,685,984 (“the ’984 patent”), and 8,809,265…the ’265 patent”)1. Gilead alleges that the ’159, ’386, ’106, ’984, and ’265 patents are invalid…consolidated action with claims for declaratory relief of patent invalidity and unenforceability and state law …infringement of the ’159, ’386, ’106, ’984, and ’265 patents by marketing and sale of Gilead’s fixed dose combination External link to document
2015-03-13 86 #39;s first two patent applications-Patent Nos. 8,466,159 (the"' 159 patent") and 8,492,386…quot;386 patent"). (Id.,~ 150.) Later that day, after it learned of the issued patents, Gilead …December 9, 2013, the European Patent Office rejected AbbVie's pending patent applications for the Combination…(collectively, "Gilead") brought this patent infringement suit against defendants Abbott Laboratories…AbbVie falsely and knowingly represented to the U.S. Patent and Trademark Office ("PTO") that it External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Moodys
Dow
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.